Skip to main content
. Author manuscript; available in PMC: 2008 Jun 10.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 May;14(5):538–545. doi: 10.1016/j.bbmt.2008.02.014

Table 3. Multiple Regression Analysis for Acute and Chronic GVHD (aGVHD, cGVHD).

Grade II-IV aGVHD
Relative Risk of GVHD (95% CI) P-Value
Conditioning regimen
 Myeloablative 1.0
 Nonmyeloablative 1.3 (0.8-2.2) .23
Donor type
 Matched related 1.0
 Unrelated/mismatched related 1.6 (0.8-2.9) .16
 Umbilical cord blood 1.3 (0.7-2.2) .38
cGVHD
Relative Risk of GVHD (95% CI) P-Value
Conditioning regimen
 Myeloablative 1.0
 Nonmyeloablative 2.2 (1.3-3.9) <.01
Donor type
 Matched related 1.0
 Unrelated/mismatched related 0.9 (0.4-1.8) .63
 Umbilical cord blood 0.5 (0.3-0.9) .03

CI indicates confidence interval; GVHD, graft-versus-host disease.